Literature DB >> 19690137

MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.

Alba Navarro1, Sílvia Beà, Verónica Fernández, Miriam Prieto, Itziar Salaverria, Pedro Jares, Elena Hartmann, Anna Mozos, Armando López-Guillermo, Neus Villamor, Dolors Colomer, Xavier Puig, German Ott, Francesc Solé, Sergi Serrano, Andreas Rosenwald, Elías Campo, Luis Hernández.   

Abstract

The contribution of microRNAs (miR) to the pathogenesis of mantle cell lymphoma (MCL) is not well known. We investigated the expression of 86 mature miRs mapped to frequently altered genomic regions in MCL in CD5(+)/CD5(-) normal B cells, reactive lymph nodes, and purified tumor cells of 17 leukemic MCL, 12 nodal MCL, and 8 MCL cell lines. Genomic alterations of the tumors were studied by single nucleotide polymorphism arrays and comparative genomic hybridization. Leukemic and nodal tumors showed a high number of differentially expressed miRs compared with purified normal B cells, but only some of them were commonly deregulated in both tumor types. An unsupervised analysis of miR expression profile in purified leukemic MCL cells revealed two clusters of tumors characterized by different mutational status of the immunoglobulin genes, proliferation signature, and number of genomic alterations. The expression of most miRs was not related to copy number changes in their respective chromosomal loci. Only the levels of miRs included in the miR-17-92 cluster were significantly related to genetic alterations at 13q31. Moreover, overexpression of miR-17-5p/miR-20a from this cluster was associated with high MYC mRNA levels in tumors with a more aggressive behavior. In conclusion, the miR expression pattern of MCL is deregulated in comparison with normal lymphoid cells and distinguishes two subgroups of tumors with different biological features.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690137     DOI: 10.1158/0008-5472.CAN-09-1095

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

3.  The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.

Authors:  Maxime Battistella; Martha Romero; Luis-Jaime Castro-Vega; Guillaume Gapihan; Fatiha Bouhidel; Martine Bagot; Jean-Paul Feugeas; Anne Janin
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

4.  Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.

Authors:  Joshua D Schiffman; Patrick D Lorimer; Vladimir Rodic; Mona S Jahromi; Jonathan M Downie; Michael G Bayerl; Jennifer N Sanmann; Pamela A Althof; Warren G Sanger; Phillip Barnette; Sherrie L Perkins; Rodney R Miles
Journal:  Br J Haematol       Date:  2011-10-08       Impact factor: 6.998

5.  Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.

Authors:  Fuad Huaman Garaicoa; Alejandro Roisman; Mariana Arias; Carla Trila; Miguel Fridmanis; Alejandra Abeldaño; Silvia Vanzulli; Marina Narbaitz; Irma Slavutsky
Journal:  Tumour Biol       Date:  2016-07-29

Review 6.  Molecular pathogenesis of mantle cell lymphoma.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

7.  miR-19 is a key oncogenic component of mir-17-92.

Authors:  Virginie Olive; Margaux J Bennett; James C Walker; Cong Ma; Iris Jiang; Carlos Cordon-Cardo; Qi-Jing Li; Scott W Lowe; Gregory J Hannon; Lin He
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

8.  CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

Authors:  Itziar Salaverria; Cristina Royo; Alejandra Carvajal-Cuenca; Guillem Clot; Alba Navarro; Alejandra Valera; Joo Y Song; Renata Woroniecka; Grzegorz Rymkiewicz; Wolfram Klapper; Elena M Hartmann; Pierre Sujobert; Iwona Wlodarska; Judith A Ferry; Philippe Gaulard; German Ott; Andreas Rosenwald; Armando Lopez-Guillermo; Leticia Quintanilla-Martinez; Nancy L Harris; Elaine S Jaffe; Reiner Siebert; Elias Campo; Sílvia Beà
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

9.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Authors:  Jian-Jun Zhao; Jianhong Lin; Tint Lwin; Hua Yang; Jianping Guo; William Kong; Sophie Dessureault; Lynn C Moscinski; Dorna Rezania; William S Dalton; Eduardo Sotomayor; Jianguo Tao; Jin Q Cheng
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

10.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-12-17       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.